
معرفی
Nusa Krivec is a Scientific employee specializing in Basic (bio-) Medical Sciences and Genetics, Reproduction and Development at the Faculty of Medicine and Pharmacy of Vrije Universiteit Brussel (VUB) in Belgium. Her research primarily focuses on stem cell biology, with expertise in stem cell in vitro culture, qPCR, immunostaining, and microscopy techniques.
Her research interests span across multiple domains of stem cell biology:
- Pluripotent Stem Cells and their applications in regenerative medicine
- Human Embryonic Stem Cells and their differentiation processes
- Germ Layer formation and development
- Endoderm differentiation and related pathways
- Genetic Background effects on stem cell behavior
- Chromosomes and in vitro techniques in stem cell research
Nusa Krivec has been actively investigating how chromosomal abnormalities affect the growth and differentiation capacity of human pluripotent stem cells. Her work bridges basic stem cell biology with cancer research, examining how genetic instabilities in stem cells might contribute to tumorigenic potential. Recent publications demonstrate her expertise in modeling liver development and cancer using stem cell-derived organoids, as well as investigating the molecular mechanisms behind chromosomal abnormalities in stem cells.
She has received recognition for her work with an h-index of 10, reflecting significant impact in her field. Her research has been cited multiple times, and her work has been featured across academic platforms and social media channels including X (Twitter), Bluesky, and news outlets, with substantial readership on academic networking sites like Mendeley.
Nusa Krivec led the FWOTM1016 project from November 2020 to October 2024, titled 'The impact of recurrent chromosomal abnormalities on growth advantage and differentiation capacity of human pluripotent stem cells,' which investigated how specific chromosomal changes affect stem cell behavior. This project contributed significantly to understanding the relationship between genetic abnormalities in stem cells and their potential for cancer development.



